Department of Public Health, College of Medicine and Health Science, Ambo University, Ambo, Ethiopia.
Department of Radiology, School of Medicine, Addis Ababa University, Addis Ababa, Ethiopia.
PLoS One. 2021 Mar 2;16(3):e0247945. doi: 10.1371/journal.pone.0247945. eCollection 2021.
Remaining underweight during Tuberculosis (TB) treatment is associated with a higher risk of unsuccessful TB treatment outcomes and relapse. Previous studies conducted in Ethiopia found that bodyweight not adjusted for height at the start of treatment is associated with poor treatment outcomes. However, the association of body mass index (BMI) and weight change during treatment with treatment outcomes has not been studied. We aimed to investigate the association of BMI at the time of diagnosis and after two months of treatment and TB treatment outcomes.
Using an ambi-directional cohort study design (retrospective and prospective), a total of 456 participants were enrolled among 30 randomly selected public health centers residing within six sub-cities of Addis Ababa, Ethiopia. Data were collected using medical chart abstraction and face to face interviews. We compared TB treatment outcomes in persons with a body mass index (BMI) <18.5kg/m2 (underweight) versus persons with BMI ≥18.5kg/m2 (normal or overweight) at treatment initiation and after two months of treatment. Treatment was classified as successful in persons who were free of symptoms and had a negative sputum smear for acid-fast bacilli at the end of the 6-month treatment course. We analysed outcomes using univariable and multivariable logistic regression with 95% CI and p value< 0.05.
Of enrolled study participants, 184 (40.4%) were underweight and 272 (59.6%) were normal or overweight. Body mass index (BMI ≥18.5kg/m2) at the start and second month of treatment were independent predictors for successful treatment outcome (AOR = 2.15; 95% CI: 1.05, 4.39) and (AOR = 3.55; 95% CI: 1.29, 9.73), respectively. The probability of treatment success among patients with BMI≥18.5kg/m2 at the start and second month of treatment was 92.9% and 97.1%, respectively versus 86.5% and 91.7% in patients with BMI<18.5kg/m2. Bodyweight not adjusted for height and change in the bodyweight after the second and sixth months of treatment were not significantly associated with treatment success.
In persons treated for TB disease, being underweight at baseline and after two months of treatment was a predictor for unsuccessful treatment outcomes. Nutritional assessment, counselling, and management are important components of TB treatment programs with the potential to improve treatment outcomes.
结核病(TB)治疗期间体重持续减轻与治疗结局不成功和复发的风险增加有关。在埃塞俄比亚进行的先前研究发现,治疗开始时未根据身高调整的体重与治疗结局不良有关。然而,治疗期间体重指数(BMI)和体重变化与治疗结局的关系尚未得到研究。我们旨在研究诊断时和治疗两个月后的 BMI 与结核病治疗结局的关系。
使用双向队列研究设计(回顾性和前瞻性),在埃塞俄比亚亚的斯亚贝巴六个分区的 30 个随机选择的公共卫生中心共招募了 456 名参与者。数据通过病历摘录和面对面访谈收集。我们比较了治疗开始时 BMI<18.5kg/m2(体重不足)与 BMI≥18.5kg/m2(正常或超重)的人以及治疗两个月后的治疗结局。在 6 个月疗程结束时无症状且痰涂片抗酸杆菌阴性的人被归类为治疗成功。我们使用具有 95%置信区间和 p 值<0.05 的单变量和多变量逻辑回归分析结果。
在纳入的研究参与者中,184 人(40.4%)体重不足,272 人(59.6%)体重正常或超重。治疗开始时和第二个月的 BMI(BMI≥18.5kg/m2)是成功治疗结局的独立预测因素(AOR=2.15;95%CI:1.05,4.39)和(AOR=3.55;95%CI:1.29,9.73)。治疗开始和第二个月 BMI≥18.5kg/m2 的患者的治疗成功率分别为 92.9%和 97.1%,而 BMI<18.5kg/m2 的患者分别为 86.5%和 91.7%。治疗开始时未根据身高调整的体重和治疗后第二个和第六个月的体重变化与治疗成功无显著相关性。
在接受结核病治疗的人群中,基线和治疗两个月时体重不足是治疗结局不成功的预测因素。营养评估、咨询和管理是结核病治疗计划的重要组成部分,有可能改善治疗结局。